Expand DAWN Menu
DAWN MENU

DAWN Stock Posts


Unusual Option Volume

DAWN Day One Biopharmaceuticals16.43+0.67 (+4.3%)

Day One Biopharmaceuticals trades 2,534 contracts.
DAWN stock increases 13.0% after hours.

After Hours Gainer

DAWN Day One Biopharmaceuticals14.47+0.12+0.8%

After Hours:16.35+1.88 (+13.0%)

Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

Globe NewswireWed, 30-Oct 4:01 PM

DAWN stock increases 12.6% after hours.

After Hours Gainer

DAWN Day One Biopharmaceuticals14.47+0.12+0.8%

After Hours:16.30+1.83 (+12.7%)

Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

Globe NewswireWed, 30-Oct 4:01 PM

Upcoming Earnings

DAWN Day One Biopharmaceuticals14.05-0.30 (-2.1%)

Day One Biopharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±10.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.1%. View Expected Move (Conf Call: Oct 30 4:30 PM)
Unusual Option Volume

DAWN Day One Biopharmaceuticals15.35-1.29 (-7.8%)

Day One Biopharmaceuticals trades 2,270 contracts. The company has the following event: Investor Update Conference Call FDA Approval Of OJEMDA on Apr 24, 2024.
Unusual Option Volume

DAWN Day One Biopharmaceuticals16.78+1.40 (+9.1%)

Day One Biopharmaceuticals trades 2,346 contracts. The company has the following event: on Apr 30, 2024.